puyuan xing
Center for National Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, China
Review Editor
Pharmacology of Anti-Cancer Drugs
- Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- Editorial Board
Type at least 3 characters
1,064 editors
Shape the future of research in your field
Join the board
Editors
Review Editors
yan xiong
West China Hospital, Sichuan University
Chengdu, China
Review Editor
Pharmacology of Anti-Cancer Drugs
daozhi xu
Shenyang Medical College
Shenyang, China
Review Editor
Pharmacology of Anti-Cancer Drugs
guang xu
Marian University
Indianapolis, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
haibo xu
Chengdu University of Traditional Chinese Medicine
Chengdu, China
Review Editor
Pharmacology of Anti-Cancer Drugs
huanli xu
Capital Medical University
Beijing, China
Review Editor
Pharmacology of Anti-Cancer Drugs
liang xu
University of Kansas
Lawrence, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
maolei xu
Binzhou Medical University
Binzhou, China
Review Editor
Pharmacology of Anti-Cancer Drugs
meng xu
Dalian Municipal Central Hospital
Dalian, China
Review Editor
Pharmacology of Anti-Cancer Drugs
wenxia xu
Zhejiang University
Hangzhou, China
Review Editor
Pharmacology of Anti-Cancer Drugs
yubin xu
Taizhou Central Hospital
Taizhou, China
Review Editor
Pharmacology of Anti-Cancer Drugs
zhiwei xu
Jiangsu University
Zhenjiang, China
Review Editor
Pharmacology of Anti-Cancer Drugs
zhou xunian
MD Anderson Cancer Center
Houston, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
yuqi yang
St. John's University
Queens, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
su-peng yeh
China Medical University Hospital
Taichung, Taiwan
Review Editor
Pharmacology of Anti-Cancer Drugs
mingo ming ho yung
The University of Hong Kong
Pokfulam, Hong Kong, SAR China
Review Editor
Pharmacology of Anti-Cancer Drugs